Herter & Co. arranges €140,000,000 real estate financing

Herter & Co. advises an international, institutional real estate investor on the successful placement of a €140,000,000 real estate financing.


Herter & Co. advises Riemser Pharma on refinancing of €286m

Herter & Co. advises Riemser Pharma GmbH ("Riemser"), a portfolio company of private equity group Ardian since 2012, on the refinancing of its existing financial indebtedness and partial repayment of the shareholder loans from Ardian's original acquisition.

Supported by Herter & Co. a financing package of €286m, thereof €256m TLB, €10m RCF and €20m was structured. The financing has been arranged by UBS Investment Bank and is currently being syndicated.



Herter & Co advises OHB SE on renewing its €225,000,000 syndicated loan ahead of schedule

Bremen, May 24, 2016. OHB SE (Prime Standard, ISIN DE0005936124) today signed a contract to renew its general facility agreement which had come into effect in December 2013. As a result, the facility has been extended ahead of schedule until May 2021 plus two one-year renewal options. At the same time, the margin has been substantially lowered and the amount of the facility reduced by EUR 25 million to EUR 225 million.


Herter & Co. advises capiton and the Hamm Reno Group GmbH & Co. KG ("HR") on the Financing of the Acquisition of a Majority stake by a group of Investors led by capiton

capiton has acquired HR,  jointly with strategic partner  Ziylan Group,  a Turkven Private Equity holding, senior retail manager Peter M. Wolf, and the HR Management Team, through an MBO.  capiton will hold a majority stake in HR Group.


Herter & Co. advises Ardian on the financing of the acquisition of d&b audiotechnik from Odewald & Compagnie and COBEPA

Herter & Co. has advised private equity group Ardian on the financing of its acquisition of d&b audiotechnik („d&b“), a company specialised on professional  acoustic systems with worldwide operations (sales of c. €94m in 2015), from investment companies Odewald & Compagnie and COBEPA.